Suchergebnisse - "Xia, Shengli"

PubPharm (7)

1

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China : Results from two studies

enthalten in: Human vaccines & immunotherapeutics | 2022

von Liu, X. | Park, J. | Xia, S. | +12

2

Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years : A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial

enthalten in: Vaccine | 2022

von Zhang, Y. | Wang, Y. | Jia, C. | +21

3

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years : a randomised, double-blind, controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Xia, S. | Zhang, Y. | Wang, Y. | +35

4

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults : A Randomized Clinical Trial

enthalten in: JAMA | 2021

von Al Kaabi, N. | Zhang, Y. | Xia, S. | +38

5

Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine : A randomized, double-blind, active-controlled phase 1 clinical trial

enthalten in: Vaccine | 2021

von Wang, Y. | Zhang, Y. | Wu, H. | +11

6

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV : a randomised, double-blind, placebo-controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2021

von Xia, S. | Zhang, Y. | Wang, Y. | +29

7

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes : Interim Analysis of 2 Randomized Clinical Trials

enthalten in: JAMA | 2020

von Xia, S. | Duan, K. | Zhang, Y. | +34

CommentIn: JAMA. 2020 Sep 8;324(10):943-945. - PMID 32789500

1
[1]